药物治疗是预防冠状动脉内介入治疗后再狭窄的最直接、最简便的方法。
Drug therapy is a most direct and convenient method for prevention of restenosis after percutaneous coronary intervention.
结论EGB对于动脉粥样硬化形成及经皮腔内冠状动脉介入治疗后再狭窄的防治可能具有应用前景。
CONCLUSION EGB may have some potential clinical implication in the prevention and treatment of atherosclerosis and restenosis after percutaneous transluminal coronary angioplasty.
随着对冠状动脉介入治疗后再狭窄机理研究的进展和涂层支架技术的研发成功，使药物涂层支架预防再狭窄成为可能。
With the progress of studying restenosis mechanism after coronary interventions therapy and successness of coated stent technology, it is possible to prevent from the restenosis by coated stents.
应用推荐